LGALS3 and Myocardial fibrosis: Indeed, Gal-3 turns quiescent fibroblasts into active myofibroblasts, and thus, increasing the collagen deposition, and ventricular dysfunction [80] whereas pharmacological or genetic inhibition of Gal-3 attenuates cardiac remodeling and myocardial fibrosis [81].